DE69936148D1 - Vitronektin rezeptor antagonist arzneimitteln oder diagnostika - Google Patents
Vitronektin rezeptor antagonist arzneimitteln oder diagnostikaInfo
- Publication number
- DE69936148D1 DE69936148D1 DE69936148T DE69936148T DE69936148D1 DE 69936148 D1 DE69936148 D1 DE 69936148D1 DE 69936148 T DE69936148 T DE 69936148T DE 69936148 T DE69936148 T DE 69936148T DE 69936148 D1 DE69936148 D1 DE 69936148D1
- Authority
- DE
- Germany
- Prior art keywords
- novel compounds
- present
- contrast agent
- treatment
- provides novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4806—Details not adapted to a particular type of sample
- G01N25/4813—Details not adapted to a particular type of sample concerning the measuring means
- G01N25/482—Details not adapted to a particular type of sample concerning the measuring means concerning the temperature responsive elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
- G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00306—Reactor vessels in a multiple arrangement
- B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
- B01J2219/00315—Microtiter plates
- B01J2219/00317—Microwell devices, i.e. having large numbers of wells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00495—Means for heating or cooling the reaction vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
- B01J2219/00707—Processes involving means for analysing and characterising the products separated from the reactor apparatus
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Combustion & Propulsion (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11282998P | 1998-12-18 | 1998-12-18 | |
US112829P | 1998-12-18 | ||
PCT/US1999/030312 WO2000035488A2 (en) | 1998-12-18 | 1999-12-17 | Vitronectin receptor antagonist pharmaceuticals |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69936148D1 true DE69936148D1 (de) | 2007-07-05 |
DE69936148T2 DE69936148T2 (de) | 2008-01-24 |
Family
ID=22346047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69936148T Expired - Fee Related DE69936148T2 (de) | 1998-12-18 | 1999-12-17 | Vitronektinrezeptorantagonist-arzneimittel |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1140203B1 (de) |
AT (1) | ATE362772T1 (de) |
AU (1) | AU2371500A (de) |
CA (1) | CA2346935A1 (de) |
DE (1) | DE69936148T2 (de) |
DK (1) | DK1140203T3 (de) |
ES (1) | ES2288040T3 (de) |
PT (1) | PT1140203E (de) |
TR (1) | TR200101775T2 (de) |
WO (1) | WO2000035488A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6794518B1 (en) | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
EP1296678A2 (de) * | 2000-06-21 | 2003-04-02 | Bristol-Myers Squibb Pharma Company | Arzneimittel mit vitronektin-rezeptor-antagonistischer wirkung zur anwendung in der kombinationstherapie |
TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
MXPA04007188A (es) | 2002-01-24 | 2005-10-18 | Barnes Jewish Hospital | Agentes para imagen dirigidos a integrina. |
US7279150B2 (en) | 2002-01-24 | 2007-10-09 | Barnes-Jewish Hospital | Chelating agents with lipophilic carriers |
US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
GB0305422D0 (en) * | 2003-03-10 | 2003-04-16 | Univ Open | Detection, monitoring and treatment of cancer |
CA2525396A1 (en) * | 2003-05-12 | 2004-11-25 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist compounds and their use in the preparation of radiopharmaceuticals |
US7319149B2 (en) | 2003-06-13 | 2008-01-15 | Bristol-Myers Squibb Pharma Company | Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
JP2008502726A (ja) | 2004-06-09 | 2008-01-31 | ケレオス インコーポレーティッド | キレートモノアミドの親油性誘導体 |
US20080095704A1 (en) * | 2004-07-02 | 2008-04-24 | Alan Cuthbertson | Imaging Agents with Improved Pharmacokinetic Profiles |
PL3929196T3 (pl) * | 2013-09-24 | 2023-12-11 | Fujifilm Corporation | Kompozycja farmaceutyczna związku zawierającego atom azotu lub jego soli, lub ich kompleksu z metalem |
LT3275883T (lt) * | 2015-03-25 | 2021-08-25 | Fujifilm Corporation | Naujo azotą turinčio junginio arba jo druskos gamybos būdas ir jo tarpinio junginio gamyba |
JP6286467B2 (ja) * | 2015-03-25 | 2018-02-28 | 富士フイルム株式会社 | インテグリンが関与する疾患の診断または治療の処置剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0762882A4 (de) * | 1994-06-29 | 2002-09-11 | Smithkline Beecham Corp | Vibronectin-rezeptor-antagonisten |
GB9511989D0 (en) * | 1995-06-13 | 1995-08-09 | Glaxo Group Ltd | Chemical compounds |
JPH11510814A (ja) * | 1995-08-30 | 1999-09-21 | ジー.ディー.サール アンド カンパニー | インテグリンアンタゴニストとしてのメタ−グアニジン、尿素、チオ尿素またはアザ環状アミノ安息香酸誘導体 |
AU1345697A (en) * | 1995-12-22 | 1997-07-17 | Du Pont Merck Pharmaceutical Company, The | Novel integrin receptor antagonists |
ZA978758B (en) * | 1996-10-02 | 1999-03-30 | Du Pont Merck Pharma | Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents |
AU4753997A (en) * | 1996-10-16 | 1998-05-11 | Burnham Institute, The | Magnetic resonance imaging of thrombi |
AU8689798A (en) * | 1997-08-04 | 1999-02-22 | Smithkline Beecham Corporation | Integrin receptor antagonists |
EP1100506A4 (de) * | 1998-07-29 | 2002-06-26 | Merck & Co Inc | Integrin rezeptor antagonisten |
-
1999
- 1999-12-17 AU AU23715/00A patent/AU2371500A/en not_active Abandoned
- 1999-12-17 CA CA002346935A patent/CA2346935A1/en not_active Abandoned
- 1999-12-17 WO PCT/US1999/030312 patent/WO2000035488A2/en active IP Right Grant
- 1999-12-17 TR TR2001/01775T patent/TR200101775T2/xx unknown
- 1999-12-17 EP EP99967442A patent/EP1140203B1/de not_active Expired - Lifetime
- 1999-12-17 PT PT99967442T patent/PT1140203E/pt unknown
- 1999-12-17 DE DE69936148T patent/DE69936148T2/de not_active Expired - Fee Related
- 1999-12-17 ES ES99967442T patent/ES2288040T3/es not_active Expired - Lifetime
- 1999-12-17 DK DK99967442T patent/DK1140203T3/da active
- 1999-12-17 AT AT99967442T patent/ATE362772T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1140203E (pt) | 2007-08-30 |
TR200101775T2 (tr) | 2002-07-22 |
ES2288040T3 (es) | 2007-12-16 |
CA2346935A1 (en) | 2000-06-22 |
WO2000035488A2 (en) | 2000-06-22 |
AU2371500A (en) | 2000-07-03 |
WO2000035488A3 (en) | 2000-11-09 |
EP1140203B1 (de) | 2007-05-23 |
DE69936148T2 (de) | 2008-01-24 |
DK1140203T3 (da) | 2007-09-10 |
EP1140203A2 (de) | 2001-10-10 |
ATE362772T1 (de) | 2007-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000035492A3 (en) | Vitronectin receptor antagonist pharmaceuticals | |
WO1999058162A3 (en) | Pharmaceuticals for the imaging of angiogenic disorders | |
WO2000035887A3 (en) | Vitronectin receptor antagonist pharmaceuticals | |
DE69936148D1 (de) | Vitronektin rezeptor antagonist arzneimitteln oder diagnostika | |
US6212423B1 (en) | Diagnostic hybrid probes | |
O'Connell et al. | Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET | |
WO2001098294A3 (en) | Vitronectin receptor antagonist pharmaceuticals for use in combination therapy | |
Grant et al. | Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial | |
WO2001097860A3 (en) | Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy | |
WO2001097861A3 (en) | Vitronectin receptor antagonist pharmaceuticals | |
Catalano et al. | Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis | |
Sharma et al. | Advanced small animal conformal radiation therapy device | |
Kabasakal et al. | Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases | |
Lentle et al. | The scintigraphic findings in Paget's disease of bone | |
IL152941A0 (en) | Fused heterocyclic compounds and kits and pharmaceutical compositions containing the same | |
DE60033697D1 (de) | Radiomarkierte vip-analoge zur diagnose und therapie | |
AR023069A1 (es) | Productos farmaceuticos antagonistas del receptor de vitronectina | |
Lekakis et al. | Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging | |
Sugishita et al. | Medical activities of synchrotron radiation in Japan—Intravenous coronary cineangiography— | |
Gallastegui | Nuclear Medicine (Including PET) | |
Nadkarni et al. | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging | |
RU2210316C2 (ru) | РЕНТГЕНОСКОПИЯ С ИСПОЛЬЗОВАНИЕМ КKα-ИЗЛУЧЕНИЯ ГАДОЛИНИЯ | |
Chow et al. | Recent developments in pancreatic cancer radiotherapy | |
Reuland et al. | Application of the murine anti-Gd-2 antibody 14. Gd-2a for diagnosis and therapy of neuroblastoma | |
Roivainen et al. | In Vivo Imaging of Inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |